The Bonnie J. Addario Lung Cancer Foundation, in collaboration with the Van Auken Private Foundation, announced the 2018 Young Innovators Team Award to fund and support teams of young investigators conducting innovative research with a potential of delivering meaningful and measurable results in the field of lung cancer.
The FY18 Defense Appropriations Act provides $100 million to the Department of Defense Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.
The Colorectal Cancer Alliance announced up to $775,000 in available funding for research in young-onset colorectal cancer, rectal cancer, and colorectal cancer prevention. The Alliance will award up to five research grants for work that will advance its mission of ending colorectal cancer within our lifetime. The grants will be awarded through the Chris4Life Research […]
The Neuroendocrine Tumor Research Foundation announced its latest Request for Applications and invites innovative research applications in neuroendocrine tumors that can bring the field closer to more effective therapies.
The FY18 Defense Appropriation provides $15 million to the Department of Defense Kidney Cancer Research Program to support the United States Medical Research Acquisition Activity.
The Cancer Prevention and Research Institute of Texas is unveiling a new award mechanism targeting early-stage oncology startup companies. Under this program, known as the Seed Award, companies can apply for up to $3 million in nondilutive funding to support development of innovative cancer therapeutics, diagnostics or tools.
FY18 OCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.
Breast Cancer Research Program: Applications submitted to the FY18 BCRP must address one or more of the following overarching challenges:
The American Association for Cancer Research and AstraZeneca formed a partnership to help foster the next generation of cancer research scientists and stimulate innovative research in the areas of DNA Damage Response in cancer and Immuno-Oncology. This funding opportunity, funded by a grant of $2.9 million from AstraZeneca, will provide support for 12 meritorious postdoctoral... […]
Due to the current Continuing Resolution, the FY18 Defense Appropriations bill has not been passed. Although funds have not been appropriated for the Department of Defense Peer Reviewed Cancer Research Program, the PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY18 funding opportunities.
